Related references
Note: Only part of the references are listed.Injectable host-guest gel nanovaccine for cancer immunotherapy against melanoma
Kaige Xu et al.
MATERIALS TODAY ADVANCES (2022)
Anti-tumor immunity by transcriptional synergy between TLR9 and STING activation
Burcu Temizoz et al.
INTERNATIONAL IMMUNOLOGY (2022)
Context-dependent functions of pattern recognition receptors in cancer
Si Ming Man et al.
NATURE REVIEWS CANCER (2022)
Overcoming TGFβ-mediated immune evasion in cancer
Daniele V. F. Tauriello et al.
NATURE REVIEWS CANCER (2022)
Strategies in DNA vaccine for melanoma cancer
Tayebeh Rezaei et al.
PIGMENT CELL & MELANOMA RESEARCH (2021)
Supramolecular Assembled Programmable Nanomedicine As In Situ Cancer Vaccine for Cancer Immunotherapy
Yu Zhang et al.
ADVANCED MATERIALS (2021)
Immune checkpoint blockade in the treatment of malignant tumor: current statue and future strategies
Wenwen Yang et al.
CANCER CELL INTERNATIONAL (2021)
Anti-pulmonary metastases from cervical cancer responses induced by a human papillomavirus peptide vaccine adjuvanted with CpG-oligodeoxynucleotides in vivo
Jinguo Suo et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Myeloid cell-targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell-mediated immunity
Dayson Moreira et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Enhancing anti-tumour efficacy with immunotherapy combinations
Funda Meric-Bernstam et al.
LANCET (2021)
Radiotherapy-Immunotherapy Combination: How Will We Bridge the Gap Between Pre-Clinical Promise and Effective Clinical Delivery?
Erminia Romano et al.
CANCERS (2021)
Regulatory B cells, A to Z
Kirstin Jansen et al.
ALLERGY (2021)
mRNA vaccine for cancer immunotherapy
Lei Miao et al.
MOLECULAR CANCER (2021)
Targeted In Vivo Delivery of NF-κB Decoy Inhibitor Augments Sensitivity of B Cell Lymphoma to Therapy
Zhuoran Zhang et al.
MOLECULAR THERAPY (2021)
Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activity
Ahmed Younes et al.
TRANSLATIONAL ONCOLOGY (2021)
Evaluation of TMB as a predictive biomarker in patients with solid cancers treated with anti-PD-1/CTLA-4 combination immunotherapy
Oliver Klein et al.
CANCER CELL (2021)
Complete rejection of large established breast cancer by local immunochemotherapy with T cell activation against neoantigens
Junxia Gao et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Encapsulation of a CpG oligonucleotide in cationic liposomes enhances its local antitumor activity following pulmonary delivery in a murine model of metastatic lung cancer
Cristina Loira-Pastoriza et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
Cyclophosphamide loaded thermo-responsive hydrogel system synergize with a hydrogel cancer vaccine to amplify cancer immunotherapy in a prime-boost manner
Fan Yang et al.
BIOACTIVE MATERIALS (2021)
Nanoparticle-mediated synergistic chemoimmunotherapy for tailoring cancer therapy: recent advances and perspectives
Rafieh Bagherifar et al.
JOURNAL OF NANOBIOTECHNOLOGY (2021)
Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine
Junhua Mai et al.
ADVANCED SCIENCE (2021)
A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic Nanovaccines
Hanze Hu et al.
ADVANCED SCIENCE (2021)
T cell infiltration on local CpG-B delivery in early-stage melanoma is predominantly related to CLEC9A+CD141+ cDC1 and CD14+ antigen-presenting cell recruitment
Bas D. Koster et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
In Situ Tumor Vaccination with Nanoparticle Co-Delivering CpG and STAT3 siRNA to Effectively Induce Whole-Body Antitumor Immune Response
Worapol Ngamcherdtrakul et al.
ADVANCED MATERIALS (2021)
Chimeric antigen receptor- and natural killer cell receptor-engineered innate killer cells in cancer immunotherapy
Cai Zhang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Stimulus-specific responses in innate immunity: Multilayered regulatory circuits
Stefanie Luecke et al.
IMMUNITY (2021)
CpG-Based Nanovaccines for Cancer Immunotherapy
Wenqiang Chen et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)
Immune checkpoint inhibitors in melanoma
Matteo S Carlino et al.
LANCET (2021)
Transdermal vaccination via 3D-printed microneedles induces potent humoral and cellular immunity
Cassie Caudill et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Overcoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma
Antoni Ribas et al.
CANCER DISCOVERY (2021)
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer
Carmine Carbone et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Macrophages Impair TLR9 Agonist Antitumor Activity through Interacting with the Anti-PD-1 Antibody Fc Domain
Simone Camelliti et al.
CANCERS (2021)
Photodynamic Therapy: Targeting Cancer Biomarkers for the Treatment of Cancers
Xinning Wang et al.
CANCERS (2021)
A spontaneous multifunctional hydrogel vaccine amplifies the innate immune response to launch a powerful antitumor adaptive immune response
Xiuqi Liang et al.
THERANOSTICS (2021)
Pattern recognition receptors in health and diseases
Danyang Li et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Therapeutic cancer vaccines
Mansi Saxena et al.
NATURE REVIEWS CANCER (2021)
Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes
Shulan Han et al.
THERANOSTICS (2021)
Therapeutic strategies for the costimulatory molecule OX40 in T-cell-mediated immunity
Yu Fu et al.
ACTA PHARMACEUTICA SINICA B (2020)
Photodynamic Therapy Combined with Antihypoxic Signaling and CpG Adjuvant as an In Situ Tumor Vaccine Based on Metal-Organic Framework Nanoparticles to Boost Cancer Immunotherapy
Zhixiong Cai et al.
ADVANCED HEALTHCARE MATERIALS (2020)
Dual fluorescence imaging-guided programmed delivery of doxorubicin and CpG nanoparticles to modulate tumor microenvironment for effective chemo-immunotherapy
Xia Dong et al.
BIOMATERIALS (2020)
Peptide-Based Vaccines: Current Progress and Future Challenges
Ryan J. Malonis et al.
CHEMICAL REVIEWS (2020)
Antibody Opsonization of a TLR9 Agonist-Containing Virus-like Particle Enhances In Situ Immunization
Caitlin D. Lemke-Miltner et al.
JOURNAL OF IMMUNOLOGY (2020)
B cells and tertiary lymphoid structures promote immunotherapy response
Beth A. Helmink et al.
NATURE (2020)
Directing Traffic: How to Effectively Drive T Cells into Tumors
Annabelle J. Anandappa et al.
CANCER DISCOVERY (2020)
Toll-like Receptors and the Control of Immunity
Katherine A. Fitzgerald et al.
CELL (2020)
Putting the Pieces Together: Completing the Mechanism of Action Jigsaw for Sipuleucel-T
Ravi A. Madan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer
Qianqian Ni et al.
SCIENCE ADVANCES (2020)
Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategy
J. Haanen et al.
ANNALS OF ONCOLOGY (2020)
Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial
Matthew J. Frank et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Endosomal Organization of CpG Constructs Correlates with Enhanced Immune Activation
Kwahun Lee et al.
NANO LETTERS (2020)
Nanoparticle delivery of immunostimulatory oligonucleotides enhances response to checkpoint inhibitor therapeutics
Colin G. Buss et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Toll-Like Receptor 9 Agonists in Cancer
Lilit Karapetyan et al.
ONCOTARGETS AND THERAPY (2020)
In situimmunization of a TLR9 agonist virus-like particle enhances anti-PD1 therapy
Yinwen Cheng et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Modulating the Tumour Microenvironment by Intratumoural Injection of Pattern Recognition Receptor Agonists
Olivia K. Burn et al.
CANCERS (2020)
Discrepant antitumor efficacies of three CpG oligodeoxynucleotide classes in monotherapy and co-therapy with PD-1 blockade
Tete Li et al.
PHARMACOLOGICAL RESEARCH (2020)
Hepatoma cell-intrinsic TLR9 activation induces immune escape through PD-L1 upregulation in hepatocellular carcinoma
Binghai Zhou et al.
THERANOSTICS (2020)
DNA Nanotechnology-Enabled Drug Delivery Systems
Qinqin Hu et al.
CHEMICAL REVIEWS (2019)
Immunotherapy of Melanoma: Facts and Hopes
Sarah A. Weiss et al.
CLINICAL CANCER RESEARCH (2019)
Nanoparticles for Oral Biofilm Treatments
Danielle S. W. Benoit et al.
ACS NANO (2019)
Carboplatin/paclitaxel, E7-vaccination and intravaginal CpG as tri-therapy towards efficient regression of genital HPV16 tumors
Sonia Domingos-Pereira et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Assessing the interactions between radiotherapy and antitumour immunity
Clemens Grassberger et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Release from UNC93B1 reinforces the compartmentalized activation of select TLRs
Olivia Majer et al.
NATURE (2019)
Amplified Cancer Immunotherapy of a Surface-Engineered Antigenic Microparticle Vaccine by Synergistically Modulating Tumor Microenvironment
Hongjuan Zhao et al.
ACS NANO (2019)
Tumor-Targeted Drug and CpG Delivery System for Phototherapy and Docetaxel-Enhanced Immunotherapy with Polarization toward M1-Type Macrophages on Triple Negative Breast Cancers
Lv Chen et al.
ADVANCED MATERIALS (2019)
DAMPs, PAMPs, and LAMPs in Immunity and Sterile Inflammation
Joel Zindel et al.
Annual Review of Pathology-Mechanisms of Disease (2019)
Combining alpha radiation-based brachytherapy with immunomodulators promotes complete tumor regression in mice via tumor-specific long-term immune response
Vered Domankevich et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
The Course of Immune Stimulation by Photodynamic Therapy: Bridging Fundamentals of Photochemically Induced Immunogenic Cell Death to the Enrichment of T-Cell Repertoire
Shubhankar Nath et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2019)
TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma
Matthew J. Reilley et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
A C-type CpG ODN accelerates wound healing via regulating fibroblasts and immune response
Lina Li et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition
Julie Voeller et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Improving cancer immunotherapy through nanotechnology
Michael S. Goldberg
NATURE REVIEWS CANCER (2019)
Mechanisms of resistance to immune checkpoint inhibitors
Russell W. Jenkins et al.
BRITISH JOURNAL OF CANCER (2018)
Inhaled TLR9 Agonist Renders Lung Tumors Permissive to PD-1 Blockade by Promoting Optimal CD4+ and CD8+ T-cell Interplay
Marilena Gallotta et al.
CANCER RESEARCH (2018)
Toll-like Receptor 9 Contains Two DNA Binding Sites that Function Cooperatively to Promote Receptor Dimerization and Activation
Umeharu Ohto et al.
IMMUNITY (2018)
Cancer immunotherapy beyond immune checkpoint inhibitors
Julian A. Marin-Acevedo et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Next generation of immune checkpoint therapy in cancer: new developments and challenges
Julian A. Marin-Acevedo et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial
Brigitte Dreno et al.
LANCET ONCOLOGY (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Personalized vaccines for cancer immunotherapy
Ugur Sahin et al.
SCIENCE (2018)
Eradication of spontaneous malignancy by local immunotherapy
Idit Sagiv-Barfi et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Encapsulation of Poly I:C and the natural phosphodiester CpG ODN enhanced the efficacy of a hyaluronic acid-modified cationic lipid-PLGA hybrid nanoparticle vaccine in TC-1-grafted tumors
Cunbao Liu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
PolyI: C and CpG Synergize with Anti-ErbB2 mAb for Treatment of Breast Tumors Resistant to Immune Checkpoint Inhibitors
Roxanne Charlebois et al.
CANCER RESEARCH (2017)
Designer vaccine nanodiscs for personalized cancer immunotherapy
Rui Kuai et al.
NATURE MATERIALS (2017)
Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways
Kai Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Radiation-enhanced delivery of systemically administered amphiphilic-CpG oligodeoxynucleotide
Oliver K. Appelbe et al.
JOURNAL OF CONTROLLED RELEASE (2017)
NF-kappa B signaling in inflammation
Ting Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)
Pattern recognition receptors: immune targets to enhance cancer immunotherapy
T. Shekarian et al.
ANNALS OF ONCOLOGY (2017)
Combination cancer immunotherapies tailored to the tumour microenvironment
Mark J. Smyth et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
Priti S. Hegde et al.
CLINICAL CANCER RESEARCH (2016)
Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy
Weijie Ma et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8+ T cells
Shu Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Ibrutinib enhances the antitumor immune response induced by intratumoral injection of a TLR9 ligand in mouse lymphoma
Idit Sagiv-Barfi et al.
BLOOD (2015)
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
Lorenzo Galluzzi et al.
CANCER CELL (2015)
Tumor necrosis factor receptor- associated factor 6 (TRAF6) regulation of development, function, and homeostasis of the immune system
Matthew C. Walsh et al.
IMMUNOLOGICAL REVIEWS (2015)
Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial
Encouse B. Golden et al.
LANCET ONCOLOGY (2015)
Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9
Umeharu Ohto et al.
NATURE (2015)
Combination cancer immunotherapy and new immunomodulatory targets
Kathleen M. Mahoney et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
Beatriz M. Carreno et al.
SCIENCE (2015)
Poly(I:C) and CpG-ODN combined aerosolization to treat lung metastases and counter the immunosuppressive microenvironment
Valentino Le Noci et al.
ONCOIMMUNOLOGY (2015)
Phosphorothioate modification of the TLR9 ligand CpG ODN inhibits poly(I:C)-induced apoptosis of hepatocellular carcinoma by entry blockade
Yuyi Zhang et al.
CANCER LETTERS (2014)
Combination therapy targeting toll like receptors 7, 8 and 9 eliminates large established tumors
By Gan Zhao et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2014)
The history of Toll-like receptors - redefining innate immunity
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Intratumoral Injection of CpG Oligonucleotides Induces the Differentiation and Reduces the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells
Yuko Shirota et al.
JOURNAL OF IMMUNOLOGY (2012)
Two Hundred Years of Cancer Research
Vincent T. DeVita et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Innate and Adaptive Immunity: The 2011 Nobel Prize in Physiology or Medicine
Aaron J. Ciechanover et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Natural Innate and Adaptive Immunity to Cancer
Matthew D. Vesely et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice
Sally M. Amos et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Antitumor Activity Mediated by CpG: The Route of Administration is Critical
Yanyan Lou et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Targeting the TLR9-MyD88 pathway in the regulation of adaptive immune responses
Xiaopei Huang et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice
Rupal Ramakrishnan et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Spatiotemporal Regulation of Heat Shock Protein 90-Chaperoned Self-DNA and CpG-Oligodeoxynucleotide for Type I IFN Induction via Targeting to Static Early Endosome
Koichi Okuya et al.
JOURNAL OF IMMUNOLOGY (2010)
The Immunostimulatory Activity of Unmethylated and Methylated CpG Oligodeoxynucleotide Is Dependent on Their Ability To Colocalize with TLR9 in Late Endosomes
Susan D. de Jong et al.
JOURNAL OF IMMUNOLOGY (2010)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Taro Kawai et al.
NATURE IMMUNOLOGY (2010)
Approaches to enhancing immune responses stimulated by CpG oligodeoxynucleotides
George Mutwiri et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Critical Role for Asparagine Endopeptidase in Endocytic Toll-like Receptor Signaling in Dendritic Cells
Fernando E. Sepulveda et al.
IMMUNITY (2009)
Immunogenic and tolerogenic cell death
Douglas R. Green et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Nucleic acid-sensing toll-like receptors: Beyond ligand search
Kensuke Miyake
ADVANCED DRUG DELIVERY REVIEWS (2008)
TLR9 as a key receptor for the recognition of DNA
Yutaro Kumagai et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes
You-Me Kim et al.
NATURE (2008)
The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor
Sarah E. Ewald et al.
NATURE (2008)
Signaling to NF-κB by Toll-like receptors
Taro Kawai et al.
TRENDS IN MOLECULAR MEDICINE (2007)
Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
Roberto Lande et al.
NATURE (2007)
A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA
Stanimir Ivanov et al.
BLOOD (2007)
Induction of interferon-gamma from natural killer cells by immunostimulatory CpG DNA is mediated through plasmacytoid-dendritic-cell-produced interferon-alpha and tumour necrosis factor-alpha
JD Marshall et al.
IMMUNOLOGY (2006)
Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-α induction
S Uematsu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Cancer immunotherapy: A treatment for the masses
JN Blattman et al.
SCIENCE (2004)
Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities
J Vollmer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
The leucine-rich repeat as a protein recognition motif
B Kobe et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2001)
A Toll-like receptor recognizes bacterial DNA
H Hemmi et al.
NATURE (2000)